country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-W319584

Copy Link Print Information

AMP-404

AMP-404 is an Imexon (HY-15385)-derived antitumor agent with dual functions as a cytotoxin and growth inhibitor. AMP-404 exerts significant cytotoxic effects against various sensitive, drug-resistant and primary human tumor cells, including myeloma, breast cancer, melanoma, ovarian cancer and sarcoma cells. AMP-404 effectively inhibits the growth of rat PIE 2-3 sarcoma in vivo and exhibits remarkable in vivo efficacy.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 55275-64-4
分子式: C₁₀H₉N₃O
分子量:187.20

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

AMP-404 構造式

CAS 番号: 55275-64-4

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- Cellular Effect
- 体外実験
- 体内実験
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
A-375	IC₅₀	11 μM Compound: 13	Inhibition of cell growth in (A375) melan cell line Inhibition of cell growth in (A375) melan cell line	[PMID: 9986721]
A549	IC₅₀	9 μM Compound: 13	Inhibition of cell growth in (A-549) lung cell line Inhibition of cell growth in (A-549) lung cell line	[PMID: 9986721]
L1210	IC₅₀	1.2 μM Compound: 13	Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay Inhibition of cell growth in drug sensitive L1210 leukemia cell line determined by MTT assay	[PMID: 9986721]
L1210	IC₅₀	11 μM Compound: 13	Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay Inhibition of cell growth in (L1210 leukemia) MDR cells determined by MTT assay	[PMID: 9986721]
MCF7	IC₅₀	2.6 μM Compound: 13	Inhibition of cell growth in (MCF7 breast) dox cell line Inhibition of cell growth in (MCF7 breast) dox cell line	[PMID: 9986721]
MCF7	IC₅₀	2.9 μM Compound: 13	Inhibition of cell growth in drug sensitive MCF-7 breast cell line Inhibition of cell growth in drug sensitive MCF-7 breast cell line	[PMID: 9986721]
MCF7	IC₅₀	4.3 μM Compound: 13	Inhibition of cell growth in (MCF7 breast) mitox cell line Inhibition of cell growth in (MCF7 breast) mitox cell line	[PMID: 9986721]
OVCAR-3	IC₅₀	6.8 μM Compound: 13	Inhibition of cell growth in (OVCAR-3) ovarian cell line Inhibition of cell growth in (OVCAR-3) ovarian cell line	[PMID: 9986721]
RPMI-8226	IC₅₀	5.3 μM Compound: 6	Cytotoxicity against multidrug resistant (MDR) human myeloma 8226 cells by MTT assay Cytotoxicity against multidrug resistant (MDR) human myeloma 8226 cells by MTT assay	[PMID: 14695835]
RPMI-8226	IC₅₀	5.3 μM Compound: 13	Inhibition of cell growth in drug sensitive 8226 myeloma cell line Inhibition of cell growth in drug sensitive 8226 myeloma cell line	[PMID: 9986721]
RPMI-8226	IC₅₀	8 μM Compound: 13	Inhibition of cell growth in drug resistant 8226 myeloma cell line Inhibition of cell growth in drug resistant 8226 myeloma cell line	[PMID: 9986721]
WiDr	IC₅₀	12 μM Compound: 13	Inhibition of cell growth in drug resistant WiDr colon cell line Inhibition of cell growth in drug resistant WiDr colon cell line	[PMID: 9986721]
WiDr	IC₅₀	5 μM Compound: 13	Inhibition of cell growth in drug sensitive WiDr colon cell line Inhibition of cell growth in drug sensitive WiDr colon cell line	[PMID: 9986721]

体外実験

AMP-404 (compound 13) potently inhibits the growth of a variety of established human and murine tumor cell lines, including drug-resistant mutant strains, with an IC₅₀ value range of 1.2 μM (murine sensitive L1210 leukemia) to 12 μM (human multidrug-resistant WiDr colon carcinoma)^[1].
AMP-404 (0.2-2.0 μM; 24 h) inhibits colony growth of various freshly isolated human tumor cells, with the strongest activity against myeloma, gastric cancer and sarcoma^[1].
The log (1/C) value of the anti-myeloma efficacy of AMP-404 is 5.27, which is consistent with the positive correlation between lipophilicity and cytotoxicity in human-sensitive multiple myeloma cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

AMP-404 (compound 13) (10-fold dose range) exhibits antitumor activity against PIE 2-3 sarcoma in Wistar rats^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

化学情報

CAS 番号 55275-64-4
分子量 187.20
分子式 C₁₀H₉N₃O
SMILES

N#CC1N(C(=O)NC=2C=CC=CC2)C1
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Dvorakova K. Mechanisms of imexon action in human myeloma cells[M]. The University of Arizona, 2000.

[2]. Iyengar BS, et al. Novel antitumor 2-cyanoaziridine-1-carboxamides. J Med Chem. 1999;42(3):510-514. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ